Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Colonic Neoplasms × tipiracil × Clear all

Status

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Colonic Neoplasms 1

Interventions

Bevacizumab 23 Leucovorin 15 Fluorouracil 14 Irinotecan 13 Oxaliplatin 12 Cetuximab 12 pembrolizumab 11 IFL protocol 11 Panitumumab 10 Folfox protocol 8 Capecitabine 8 Gemcitabine 7 Cisplatin 5 Carboplatin 5 adagrasib 4 Colonoscopy 4 veliparib 3 spartalizumab 3 selpercatinib 3 labetuzumab 3 conatumumab 3 Ramucirumab 3 Pemetrexed 3 Paclitaxel 3 HMPL-013 3 trifluridine tipiracil drug combination 2 trametinib 2 tislelizumab 2 regorafenib 2 pegfilgrastim 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05839951 2025-11-12

STAR-T

Bayer

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡